Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Nitric Oxide : Biology and Chemistry|May 13, 2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cellsAnna Tesei, Wainer Zoli, Francesco Fabbri, et al.International Journal of Oncology|February 14, 2013
Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell linesToni Ibrahim, Chiara Liverani, Laura Mercatali, et al.Breast Cancer Research and Treatment|March 6, 2004
c-kit and SCF expression in normal and tumor breast tissuePaola Ulivi, Wainer Zoli, Laura Medri, et al.Journal of Clinical Pathology|March 28, 2013
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissuePaola Ulivi, Maurizio Puccetti, Laura Capelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell linesLuca Ricotti, Anna Tesei, Franca De Paola, et al.Apoptosis : an International Journal on Programmed Cell Death|May 16, 2006
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell linesMarco Rosetti, Anna Tesei, Paola Ulivi, et al.Journal of Cellular Physiology|March 17, 2009
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell linesPaola Ulivi, Chiara Arienti, Dino Amadori, et al.Journal of Translational Medicine|November 1, 2007
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell linesAnna Tesei, Marco Rosetti, Paola Ulivi, et al.BMC Cancer|July 3, 2014
First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancerGianluca Tedaldi, Rita Danesi, Valentina Zampiga, et al.Oncology Letters|February 10, 2015
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximabElisa Chiadini, Emanuela Scarpi, Alessandro Passardi, et al.Pageof 10